Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Vitamin A and Reduced Bronchopulmonary Dysplasia Incidence

Doses used in studies

IU/day: 3,330 (median 3,330, IQR 3,330–3,330) — 1 study

1 of 1 paper

Clinical efficacy of different supplemental doses of vitamins A and D in preventing bronchopulmonary dysplasia in preterm infants: A network meta-analysis based on randomized controlled trials.
- 2026-05-22
- Meta-Analysis · n = 4,357
- Medicine 105(21)
- - Qingfeng Yu
  - Xiao Chen
  - Jing Chen
  - Lan Peng
  - Kui Luo
- PubMed: 42175407
- DOI: 10.1097/md.0000000000048956
3 Insights on
- Reduced Bronchopulmonary Dysplasia Incidence
- High evidence
- Infants
low-dose vitamin A (LDVA, <3330 IU/d) exhibited the lowest mortality
Effect
Neutral
Effect size
Small
Significant
No
Dose
<3330 IU/d